Unbalanced expression of membrane-bound and soluble OX40 and OX40 ligand in patients with myasthenia gravis

Xiaoling Zhou1, Xiaoyuan Wang1, Yanzheng Gu2, Lan Chen3 , Yueping Shen4, Jingluan Tian1, Mingyuan Wang5, Shujun Chen1, Xiaoyu Duan1, Hanqing Gao1, Xiaopei Ji1, Qi Fang1,2, Xueguang Zhang2,3, Qun Xue*1,21. Department of Neurology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China.2. Institute of Clinical Immunology, Jiangsu Key Laboratory of Clinical Immunology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China.3. Department of Neurology, Nantong First People’s Hospital, Nantong, Jiangsu, 226000, China.4. Department of Epidemiology and Health Statistics, Soochow University, Suzhou, Jiangsu, 215006, China.5. Suzhou Red Cross Central Blood Station, Suzhou, Jiangsu, 215006, China.*Correspondence Author: Qun Xue (email: qxue_sz@163. com)